Implantable Miniature Telescope Press Release
Patient Receives First Bionic Eye Telescope
Implant by Hawaii Surgeons
HONOLULU, Jan. 18, 2012 — Two surgeons from Hawaii, Dr. Michael McMann of the McMann Eye Institute and Dr. Michael Bennett of Retina Institute of Hawaii, have successfully implanted the FDA-approved eye telescope, a first in Hawaii, at the Queen’s Medical Center in Honolulu. The first-of-its-kind telescope implant is integral to CentraSight™, a new patient care program for treating patients with end-stage age-related macular degeneration (AMD), the most advanced form of AMD and the leading cause of blindness in older Americans. It is the only medical/surgical option that improves visual acuity by reducing the impact of the central vision blind spot caused by end-stage AMD.
Smaller than a pea, the telescope implant uses micro-optical technology to magnify images, which would normally be seen in one’s “straight ahead” or central vision. The images are projected onto the healthy portion of the retina not affected by the disease, making it possible for patients to see or discern the central vision object of interest.
Patients with end-stage AMD have a central blind spot. This vision loss makes it difficult or impossible to see faces, read, and perform everyday activities such as watching TV, preparing meals, and self-care. The telescope implant has been demonstrated in clinical trials to improve quality of life by improving patients’ vision so they can see the things that are important to them, increase their independence, and re-engage in everyday activities.
“I believe this Implantable Miniature Telescope is not only an evolutionary product, but a revolutionary one. We have patients who may never see again because of end-stage macular degeneration and this new technology provides them with another chance to potentially see their loved ones’ faces again. It is truly remarkable and exciting to be a part of,” says Dr. Michael McMann, of the McMann Eye Institute.
The treatment program is generally coordinated by retina specialists who treat macular degeneration and other back-of-the-eye disorders. The surgical insertion of the implantable miniature telescope lens is performed by the cornea surgeon. The treatment program focuses on comprehensive patient care, requiring prospective patients to undergo medical, visual, and functional evaluation to determine if they may be a good candidate. A unique aspect of the evaluation is the ability to simulate, prior to surgery, what a person may expect to see once the telescope is implanted to determine if the possible improvement will meet the patient’s expectations.
“After decade’s worth of research and development, we finally have technology capable of restoring sight and visual function for patients suffering from chronic macular degeneration,” says Dr. Michael Bennett, of the Retina Institute of Hawaii. “This is a very exciting breakthrough both in medical history and for patients who never thought they would see again.”
Dr. McMann, a cornea eye surgeon, and Dr. Bennett, a retina eye surgeon, are one of the first teams to perform the surgery nationwide. As long time colleagues, Dr. McMann and Dr. Bennett were both trained at Emory University, one of the pioneering Phase I and Phase II surgical centers for the implantable device. Their natural union combines the best of their collective cornea and retina refractive skills.
The telescope procedure is performed on an outpatient basis and is covered by Medicare. Post-implantation, the patient will learn how to use their new vision in everyday activities by working with Dr. Kellen Kashiwa, the regional CentraSight visual rehabilitation provider.
Patients and physicians can find more information about the telescope implant and related treatment program at www.CentraSight.com or by calling (888) 999-4134.
About the McMann Eye Institute
The McMann Eye Institute is an Oahu-based ophthalmic surgery practice founded in 2007 by Dr. Michael A. McMann. Dr. McMann, the founder and Medical Director of the McMann Eye Institute, has extensive training and experience in performing laser vision correction (LASIK, PRK) and advanced techniques for cataract surgery, corneal transplantation surgery, and management of corneal and external eye disease.
If you’d like more information about this topic, or to schedule an interview with Dr. McMann, please contact him at (808) 677-2733 or e-mail at info@OahuLasik.com.
SOURCE: McMann Eye Institute
# # #